MMP-9基因多态性与复发性流产的相关性研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:通过测定正常妊娠妇女和复发性流产史妇女的外周血的基质金属蛋白酶-9基因C1562T(MMP-9 C-1562T)多态性,拟从基因水平探讨MMP-9与复发性流产的相关性。
     方法:采用聚合酶链反应-限制性片段长度多态性( polymerase chain reaction-restrictive fragment length polymorphism,PCR-RFLP)分析法,对60例有复发性流产史的患者(病例组)和60例正常妊娠妇女(对照组)的MMP-9基因多态性进行分析,病例组及对照组年龄、孕周差异采用t检验;两组基因型频率及等位基因频率比较采用行列表资料的卡方检验分析,并计算表示相对风险度的优势比(odds ratio,OR)及其95%可信区间(confidence interval,CI)。
     结果:(1)病例组与对照组CT+TT基因频率分别为25%、10%,两组对比(χ~2=4.675,P﹤0.05)差异有统计学意义。(2)病例组与对照组T等位基因频率分别为12.5%、5%,两组对比(χ~2=5.483,P﹤0.05)差异有统计学意义。(3)与CC基因型和C等位基因相比,携带CT+TT基因型和T等位基因的人群能增加复发性流产的风险性,风险值分别为3.000(95%CI=1.075-8.370)、2.714(95%CI=1.015-7.255)。
     结论:(1)血清MMP-9基因多态性可能是导致复发性流产的危险因素。(2)T等位基因可能是复发性流产的遗传易感基因之一。
Objective:By determining the normal pregnant women and recurrent spontaneous abortions history woman's matrix metalloproteinases - 9 (MMP-9) gene polymorphism of peripheral blond to probe the relativity between MMP-9 gene polymorphism and recurrent spontaneous abortions.
     Methods:Using polymerase chain reaction - restriction fragment lengthpolymorphism (PCR - RFLP) analysis method to analyse sixty cases patients who have recurrent abortions history (case group) and 60 cases of normal health early pregnantwomen's (control group) MMP-9 gene polymorphism , Using t test to checkout the difference of age, gestational weeks between the case group and the control group. Comparing two groups gene frequencies and allele frequencise uses the chi-square test(χ~2 ) analysis. Calculate odds ratio(OR ) to show relative risk degree,and its 95% confidence interal (CI) .
     Results:(1) The case group and control group CT + TT gene frequencies are 10% and 25% respectively,two groups'comparison (χ~2=4.675,P﹤0.05),the difference have statistically significant.(2) The case group and control group T allele frequencise are 12.5% and 5%, respectively, two groups'comparison(χ~2=5.483,P﹤0.05) the difference have statistically significant.(3)Compared with CC genotype and C alleles, carrying CT + TT genotype and T alleles crowd can increase the risk of recurrent miscarriage, value at risk (95% CI = 3.000 1.075-8.370), 2.714 (95% CI = 1.015-7.255) respectively.
     Conclusion:(1) MMP-9 gene polymorphism in serum may be the risk factors which cause recurrent spontaneous abortions .(2) T allele may be recurrent spontaneous abortions genetic susceptibility genes.
引文
[1].Lamarca HL,Ott CM,Zu Bentrup K,etal.Three-dmiensional growth of extravillous cytotrophoblasts promotes differentiation and invasion[J].Placen ta,2005,26(10):709-720.
    [2].Zhang B,Ye S,Herrmann SM,etal.Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis[J]. Circulation,1999,99:1788-1794.
    [3].赵云阁,欧尔比特-安尼瓦尔,祝诚,细胞外基质与基质金属蛋白酶[J].生物化学与生物物理进展,1999,26(3):223-228.
    [4].Vicent AJ,Zhang J,Ostor A,etal.Matrix Metalloproteinase-1,-3 and mast cells are present in the endometrium of women using progestin-only contraceptives [J].Hum Reprod, 2000,15(1):123-130.
    [5].Kaitu,u TJ,Shen J,Zhang J, etal. Matrix metalloproteinases in endometrial breakdown and repair: functional significance in a mouse model[J].Biol Reprod.2005,73(4):672-680.
    [6].Sawick G,Radomski MW,Winkler-lowen B,etal.Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts[J].Biol Reprod,2000,63(5):1390- 1395.
    [7].张钰、李平、李奕,早期流产者绒毛和蜕膜组织中MMP-9、TIMP-3的表达及其意义[J].中国计划生育学杂志,2008,2:86-89.
    [8].Iwahashi M,Nakano R,Decreased type collagen expression in human decidualtissues of spontaneous abortion during early pregnancy[J].J Clin Pathol,1998,51(1):44-46.
    [9].Stygar D,Wang H,Vladic YS,etal.Increased Level of Matrix Metalloproteinases 2 and 9 in the ripening process of the Human Cervix[J].Biol Of Repr,2002,67(3):889-894.
    [10].李黎、陈士岭、邢福祺,基质金属蛋白酶-9及其抑制物-3在人种植窗期子宫内膜的表达特点及作用[J].中华妇产科杂志.2000,35(9):544-546.
    [11].Whiteside EJ, Jackson MM, Herington AC, etal. Matrix metalloproteinase -9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos [J].Biol Reprod. 2001, 64(5):1331-1337.
    [12].刘春晖,高云荷,郭钰珍.组织MMP一9/TIMP一3水平与自然流产关系[J].临床与实验病理学杂志,2004,20(5):551-553.
    [13].Hozumi A,Nishimura Y,Nishiuma T,et al.Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway[J].Am J Physiol Lung Cell Mol Physiol ,2001, 281 (6):L1444 -1452,
    [14].Yang JQ,Zhao W,Duan H,etal.v-Ha-RaS oncogene upregulates the 92-kDa type IVcollagenase(MMP-9)gene by increasing cellular superoxide production and activating NF-kappaB[J].Free Radic Biol Med,2001,31(4):520-529.
    [15].Galboiz Y,Shapiro S,Lahat N,etal.Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response tointerferon-beta therapy in relapsing and secondary-progressive multiple sclersis patients[J].Ann Neurol,2001,50(4):443-451.
    [16].Frankenberger M,Hauck RW,Frankenberger B,etal.All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9(MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1(TIMP-1)in human bronchialveolar lavage cells[J].Mol Med.2001,7(4):263-270.
    [17].Joos L,Peter DP,Andrew GS.Genetic risk factor for chronic obstructive pulmonary disease.SWISS MED WKLY,2002,132:27-37.
    [18].刘力华,杨尚武,王晨虹.质金属蛋白酶-9基因多态性与妊娠高血压疾病的关系研究[J].海南医学院学报,2009,15(12):1551-1553.
    [1].Liu G,Zhang X,Lin H,etal.Expression of matrix metalloproteinase-26 (MMP-26) mRNA in mouse uterus during the estrous cycle and early pregnancy[J].Life Sci,2005,77(26):3355-3365.
    [2]. Hirata M , Sato T , Tsumagari M,eta1 . Differential Regulation of the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases by Cytokines and Growth Factors in Bovine Enometrial Stromal Cells and Trophoblast Cell Line BT-1 in Vitro.Biol Reprod,2003,68(4):1276-1281.
    [3].Joannan L,Skinn,Simon C,etal.Regulation 0f matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration 0f intrauterine levonorgestrel[J].Hum Reprod,1999,14(3):793—799.
    [4]. Sawick G,Radomski MW,Winkler-lowen B,etal.Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts[J].Biol Reprod,2000,63(5):1390- 1395.
    [5]Jeziorska M,Nagase H,Salamonsen LA,etal.Immunoloealization of the matrix metralloProteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle.J ReProd Fertil,1996,107(1):43一51.
    [6].SolbergH, Rinkenberger J, Dano K,etal.A functional overlap ofplasminogen and MMPs regulates vascularization during placental development. Development, 2003, 130(18):4439-4450.
    [7].Reponen P,Leivo I,Sahlberg C,etal.92 kDa type IV collagenase and TIMP 3,but not 72 kDa IV type collagenase or TIMP-1 or TIMP-2,are highly expressed during mouse embryo implantation.Dev Dyn,1995,202(4):388- 396。
    [8]. Whiteside EJ, Jackson MM, Herington AC, etal. Matrix metalloproteinase -9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos [J].Biol Reprod,2001, 64(5):1331-1337.
    [9].李黎,陈士岭,邢福祺.基质金属蛋白酶-9及其抑制物-3在人种植窗期子宫内膜的表达特点及作用[J],中华妇产科杂志,2000, 35(9): 544-546.
    [10] .Wang H,Li Q,Shao L,et a1.Expression of matrix metalloproteinase-2,-9,-14,and tissue inhibitors of metalloproteinase-1,一2, -3 in the endometrium and placenta of rhesus monkey(Macaca mulatta)during early pregnancy[J].Biol Reprod,2001,65(1):31-40.
    [11]. Hozumi A,Nishimura Y,Nishiuma T,et al.Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway[J].Am J Physiol Lung Cell Mol Physiol ,2001, 281(6):L1444 -1452,
    [12].Yang JQ,Zhao W,Duan H,etal.v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase(MMP-9)gene by increasing cellular superoxide production and activating NF-kappaB[J].Free Radic Biol Med,2001,31(4):520-529.
    [13]. Galboiz Y,Shapiro S,Lahat N,etal.Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response tointerferon-beta therapy in relapsing and secondary-progressive multiple sclersis patients[J].Ann Neurol,2001,50(4):443-451.
    [14]. Frankenberger M,Hauck RW,Frankenberger B,etal.All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9(MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1(TIMP-1)in human bronchialveolar lavage cells[J].Mol Med.2001,7(4):263-270.
    [15].Sharma RK. Mouse trophoblastic cell lines: II—Relationship between invasive potential and proteases[J]. In Vivo. 1998,12(2): 209-217.
    [16].Lamarca HL,Ott CM,Zu Bentrup K,etal.Three-dmiensional growth of extravillous cytotrophoblasts promotes differentiation and invasion[J].Placen ta,2005,26(10):709-720.
    [17].张钰、李平、李奕.早期流产者绒毛和蜕膜组织中MMP-9、TIMP-3的表达及其意义[J].中国计划生育学杂志,2008,2:86-89.
    [18].刘春晖,高云荷,郭钰珍.蜕膜组织MMP一9/TIMP一3水平与自然流产关系[J],临床与实验病理学杂志,2004,20(5):551-553.
    [19].Iwahashi M,Nakano R.Decreased type V collagen expression in human decidualtissues of spontaneous abortion during early pregnancy[J].J Clin Pathol,1998,51(1):44-46.
    [20].谭兵兵王乾兴谭晓珊.胎盘绒毛血管生成状况及VEGF、MMP-2和MMP-9表达与早期自然流产的关系[J],生殖与避孕,2006,26(8):477-481.
    [21].Guo J, Zou L. Correlation of RECK with matrix metalloproteinase -2 in regulation of trophoblast invasion of early pregnancy [J]. J Hua zhong Univ Sci Technolog Med Sci,2006, 26(6): 738-40.
    [22].Jokimaa V,Oksjoki S,Kujari H,eta1.Altered expression of Genes involved in the production and degradation of endometrial extracellular matrix in patients with unexplained infertility and recurrent miscarriages[J].Mol Hum Reprod,2002,8(12):1111-1116.
    [23].王乾兴,谭兵兵,谭晓珊,等.早期自然流产胎盘绒毛基质金属蛋白酶-2表达增强[J],基础医学与临床,2006,26(3):323-324.
    [24].张素娥刘影.原因不明复发性流产患者蜕膜组织TGF-β1与MMP-2及TIMP-2的相关性研究[J],河北医药,2008,30(7):966-967.
    [25].Nie J, Pei D. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase25 at the asn(109)-Tyr bond[J].Cancer Res, 2003, 63(20):6758-6762.
    [26].王莉,董白桦,苏士利,等.MMP-25在早孕绒毛和蜕膜中的表达及意义的研究[J].山东大学学报(医学版),2008,46(4):415-419.
    [27].余秋波,李红梅,董艳玲,等.自然流产患者蜕膜MMPl0的表达及临床意义[J].重庆医科大学学报,2007,32(7):679-781.
    [28].Joos L,Peter DP,Andrew GS.Genetic risk factor for chronic obstructive pulmonary disease.SWISS MED WKLY,2002,132:27-37.